Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04506450
Other study ID # 721
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date December 1, 2019

Study information

Verified date August 2020
Source Università Politecnica delle Marche
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Anesthesia plays an important role in the patient's outcome: each anesthesiological technique has a different cardiovascular impact, because they act differently on the autonomic nervous system, which in turn regulates heart rate, myocardial contractility and vascular tone.

Subarachnoid anesthesia can result in a reduction in cardiac output, hypotension and bradycardia due to blockage of the nerve fibers of the sympathetic system, while peripheral nerve block is associated with a lower impact on the autonomic nervous system, therefore less influence on hemodynamic changes compared to subarachnoid anesthesia.

Hypotension can lead to myocardial ischaemia, especially in patients at high surgical risk.

In addition, peripheral nerve block allows for better coverage from postoperative pain compared to subarachnoid anesthesia in patients undergoing hip surgery.

This leads to less postoperative stress, with less impact on cardiac and respiratory function.

Numerous studies have shown the efficacy and safety of regional anesthesia in hip surgery.

This study aims to compare the hemodynamic changes of subarachnoid anesthesia and peripheral nerve block in patients who underwent total and partial hip replacement


Description:

All patients who meet the inclusion and exclusion criteria will be enrolled. Enrolled patients will be informed of the study modality. In case of a favorable opinion, the patient will be made to sign the informed consent. Subsequently a code will be assigned to the patient for randomization.

There are two randomization groups: in the PNB group the patient will undergo lumbar plexus block, sciatic nerve block, lateral femoral cutaneous nerve block and lateral branch of iliohypogastric nerve block, while in the SA group, the patient will undergo subarachnoid anesthesia and lumbar plexus block.

In the preoperative room, ECG, pulseoximetry will be estabilished and an arterial radial cannula will be inserted under local anesthesia to monitor blood pressure. A premedication with midazolam (0.05-0.1 mg / kg) will be administered before anesthesia is performed.

At this point, the type of anesthesia will be followed on the basis of the randomization group.

The following variables will be evaluated:

- hemodynamic parameters in the perioperative period

- onset time of the sensory and motor block

- fluids and vasoactive drugs administered

- anesthesiological complications

- degree of patient satisfaction

- duration of surgery

- degree of postoperative pain and analgesic therapy administered

- mini mental state evaluation (in the preoperative and postoperative period)

- start physical rehabilitation

- clinical complications during hospitalization

- duration of hospitalization


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 1, 2019
Est. primary completion date December 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- Subject has signed and dated an Informed Consent Form

- Subject is classified as a ASA (American Society of Anesthesiologists) status I-IV

- Subject is age 18- 99 years old

- Patients undergoing total hip arthroplasty

Exclusion Criteria:

- Subject inability to provide adequate informed consent

- Study refusal

- Age younger than 18 years

- Contraindication to regional anesthesia

- Allergy to local anesthetics

- Neurological disease of the lower limbs

- Moderate or severe dementia disease

- Psychiatric disease

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Peripheral nerve block
In this group, four nerve blocks will be associated to ensure adequate anesthesia and analgesia during hip surgery. Lumbar plexus and sciatic nerve blocks will be performed with a needle connected to an electrical nerve stimulation. The needle will be advanced until contraction of the femoral quadriceps muscle and plantar or dorsal flexion of the foot will be detected respectively. For both, a mixture of mepivacaine and levobupivacaine will be injected. Lateral femoral cutaneous nerve block will be performed with the ultrasound technique. After identifying the nerve, a needle will be inserted with an "in plane" approach and will be injected. Lateral branch of iliohypogastric nerve block will be executed with the "De Visme approach". Along the iliac crest (range between 7 and 11 cm from the anterior superior iliac spine) a needle will be inserted until bone contact is found. Then a mixture of mepivacaine and levobupivacaine will be injected.
Spinal anesthesia
In this group, spinal anesthesia will be performed to ensure anesthesia during surgery, while lumbar plexus block will be performed to ensure postoperative analgesia Spinal anesthesia will be performed with a 25 G needle and 12 mg 0.5% levobupivacaine will be injected. Lumbar plexus block will be performed with a needle connected to an electrical nerve stimulation. The needle will be advanced until contraction of the femoral quadriceps muscle will be detected. 20 ml 0.5% levobupivacaine will be injected.

Locations

Country Name City State
Italy Ospedali Riuniti di Ancona - Università politecnica delle marche Ancona

Sponsors (1)

Lead Sponsor Collaborator
Università Politecnica delle Marche

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of the systolic blood pressure Systolic blood pressure will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery During anesthetic and surgery procedures
Primary Change of the diastolic blood pressure Diastolic blood pressure will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery During anesthetic and surgery procedures
Primary Change of the mean blood pressure Mean blood pressure will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery During anesthetic and surgery procedures
Primary Change of the heart rate Heart rate will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery During anesthetic and surgery procedures
Secondary Change in the onset time of the nerve block Sensitivity to the lower limbs will be assessed by pinprick test and cold test after the end of the anesthetic procedure Up to 20 minutes
Secondary Change in the degree of the sensory block Sensitivity to the lower limbs will be assessed by pinprick test and cold test after the end of the anesthetic procedure Up to 20 minutes after the end of the anesthetic procedure
Secondary Change of the Motor block degree The motor block will be assessed by the Bromage scale after the end of the anesthetic procedure. Grade 1: complete block (unable to move feet or knees). Grade 2: almost complete block (able to move feet only). Grade 3: partial block (just able to move knees). Grade 4: detectable weakness of hip flexion (between score 3 and 5). Grade 5: No detectable weakness of hip flexion while supine (full flexion of knees). Grade 6: able to perform partial knee bend. Up to 20 minutes after the end of the anesthetic procedure
Secondary Amount ephedrine administered during the perioperative period Ephedrine use, mg. During anesthetic and surgery procedures
Secondary Amount atrophine administered during the perioperative period Atropine use, mg. During anesthetic and surgery procedures
Secondary Amount Fluids administered during the perioperative period All fluids administered, ml. During anesthetic and surgery procedures
Secondary Degree of patient satisfaction the degree of patient satisfaction will be measured on a scale ranging from 0 to 3 (0= bad; 1= not bad; 2=good; 3=excellent) At the end of surgery
Secondary Duration of surgery minutes During surgery
Secondary Postoperative pain score 11-point numeric rating scale ranging from '0' representing one extreme (e.g. "extremely dissatisfied") to '10' representing the other extreme (e.g. "extremely satisfied") 1, 3, 6, 12, 24, 36, 48 hours after the end of surgery
Secondary Amount of analgesic drugs administered Paracetamol use, mg; Morphine use, mg; Ketorolac use, mg. 1, 3, 6, 12, 24, 36, 48 hours after the end of surgery
Secondary Assessment of mental state It will be evaluated through the mini mental state evaluation Preoperative; 24 hours after the end of surgery; 48 h after the end of surgery, 72 h after the end of surgery and 96 h after the end of surgery.
Secondary Beginning of physical rehabilitation number of day Immediately after the surgery
Secondary Anesthetic and surgery complications Assessment for existence of complications related to procedures in form of Y/N (such as hypotension, bradycardia, local anesthetic epidural spread, local anesthetic systemic toxicity, nausea and vomiting During anesthetic and surgery procedures
Secondary Clinical complications Assessment for existence of complications related to procedures in form of Y/N (such as neuropathy, nausea and vomiting, heart and vascular diseases, respiratory dysfunction, urinary retention, renal failure, cognitive disorder, death Immediately after the surgery
Secondary Duration of hospitalization Duration (day) of hospital stay Up to one month
See also
  Status Clinical Trial Phase
Completed NCT02275494 - The Influence of Leg Length Discrepancy After Total Hip Arthroplasty on Function and Quality of Life N/A
Completed NCT00967980 - Femoral Versus Psoas Continuous Peripheral Nerve Blocks Following Hip Arthroplasty Phase 4
Completed NCT03585647 - Anesthetic Methods and Gene Expression Profile
Not yet recruiting NCT06009432 - Efficacy of Proprioceptive Neuromuscular Facilitation Exercise Program in Total Hip Arthroplasty N/A
Completed NCT06009419 - Effectiveness of Dual Task Training in Total Hip Arthroplasty N/A
Completed NCT00921908 - Multihole or Epidural Catheter for Local Anesthetic in the Wound N/A
Completed NCT00367289 - CT for Diagnosis of Implant Stability in Revision Arthroplasty N/A
Completed NCT00253838 - A Comparison of Two Type of Stems in Revision Hip Arthroplasty N/A
Enrolling by invitation NCT04592939 - Trial of Weight Bearing Status Following Femoral Revision With Tapered, Fluted, Titanium Stems N/A
Not yet recruiting NCT03259672 - Influence of Sevoflurane and Desflurane on Postoperative Sore Throat N/A
Completed NCT00912873 - Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks Phase 4
Recruiting NCT05807828 - VR Simulation and Basic Skills in THA N/A
Terminated NCT00621530 - Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip Replacement Phase 2
Recruiting NCT04426058 - CMP vs Fascia Iliaca Block N/A
Terminated NCT02818764 - Delirium, Intraoperative Cerebral Perfusion and EEG Abnormalities After Total Hip Arthroplasty
Completed NCT00261040 - Minimally Invasive Surgery of the Hip Versus Standard Approach N/A
Completed NCT03173339 - Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia N/A
Completed NCT03035435 - Fast-track Rehabilitation After Total Knee or Hip Arthroplasty N/A
Completed NCT01520961 - Functional Recovery After Partial Hip Arthroplasty: Anterior or Posterolateral Approach? N/A
Terminated NCT00934661 - Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing Phase 4